Anatomic outcomes of laser indirect ophthalmoscopy for retinopathy of prematurity in a tertiary referral center in the Philippines

Chan, David Francis Fullon; Herrera-Arroyo, Milagros

doi:10.1186/s13104-019-4303-3

Cited by 3 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Poorer outcomes were noted compared with published data (success rate of 60% vs 90%). 21 Limitation and poor outcomes of this study were attributed to lack of uniformity in data collection, and insufficient identification of prenatal and perinatal risk factors. This stresses the importance of proper documentation of these risk factors from all involved in the care of preterm infants in identifying those requiring ROP screening.…”

Section: Open Accessmentioning

confidence: 91%

See 1 more Smart Citation

Comparison of the detection rates for retinopathy of prematurity (ROP) of the 2013 Philippine Academy of Ophthalmology (PAO) Revised Philippine Guidelines and the 2005 PAO-Philippine Pediatric Society (PPS) Guidelines for ROP screening in the Philippine General Hospital: a 5-year review

Paulino

Santiago

2020

BMJ Open Ophth

View full text Add to dashboard Cite

ObjectivesCompare the detection rates of the 2013 Philippine Academy of Ophthalmology (PAO) guidelines for retinopathy of prematurity (ROP) screening and the 2005 PAO-Philippine Pediatric Society guidelines in identifying infants who develop ROP in the 5-year study period in the Philippine General Hospital (PGH). Secondary objectives include determination of ROP prevalence; correlation of gestational age (GA), birth weight (BW) and other risk factors to ROP; and identification of the most common intervention.Methods and analysisRetrospective cross-sectional study of ROP records between 1 December 2013 and 30 November 2018 from the Medical Retina Service of the Department of Ophthalmology and Visual Sciences of the institution was studied. Variables with p value <0.05 were considered significant. STATA V.14 was used for all analysis.ResultsOnly 851 of 898 infants screened for ROP were included in the study. Of these 698 would have been screened based on 2005 guidelines. All 118 infants with ROP were identified by both guidelines. Detection rate was higher using the 2005 than the 2013 guidelines (16.9% vs 13.3%, p value=0.0496). ROP prevalence was 9.7%. Among those with ROP, 70% have at least one identified risk factor, topped by sepsis, pneumonia, hyaline membrane disease, blood transfusion and oxygen supplementation. Only 8% required intervention consisting of laser, anti-vascular endothelial growth factor injection, surgery or in combination.ConclusionIn PGH, no infants with ROP were missed using the 2005 recommendations. There was no added benefit of increasing threshold for BW and GA as recommended by the 2013 PAO guidelines. Screening guidelines should, however, be tailored to institutional needs, requirements and experience.

show abstract

Section: Open Accessmentioning

confidence: 91%

“…Chan and Herrera-Arroyo 21 investigated outcomes of LIO for ROP in the same institution. Poorer outcomes were noted compared with published data (success rate of 60% vs 90%).…”

Section: Open Accessmentioning

confidence: 99%

Comparison of the detection rates for retinopathy of prematurity (ROP) of the 2013 Philippine Academy of Ophthalmology (PAO) Revised Philippine Guidelines and the 2005 PAO-Philippine Pediatric Society (PPS) Guidelines for ROP screening in the Philippine General Hospital: a 5-year review

Paulino

Santiago

2020

BMJ Open Ophth

View full text Add to dashboard Cite

show abstract

Impact and Trends in Global Ophthalmology

Williams

Prakalapakorn

Ansari

et al. 2020

Curr Ophthalmol Rep

View full text Add to dashboard Cite

Evaluation of Outcomes and Regression after Neovascularization Treatment for Non-type 1 Retinopathy of Prematurity

Titawattanakul¹

2023

TOOPHTJ

View full text Add to dashboard Cite

Introduction: To study the unfavorable outcomes and regression after neovascularization treatment for non-type 1 retinopathy of prematurity (ROP) in a tertiary care facility in Thailand. Methods: A retrospective study was done of all infants undergoing screening and treatment for ROP at a tertiary referral center between July 2018 and June 2021 with follow-up for 60 weeks postmenstrual ages (PMA). The outcomes measured were unfavorable outcomes, including macula involving posterior retinal folds, macula involving retinal detachment, retrolental cicatrix formation, or a mass obscuring the view of the posterior pole, and the regression of ROP after treatment. The infants received neovascularization treatment (stage 3 ROP) within 72 h of diagnosis. The study also compared the unfavorable outcomes and regression between neovascularization in type 1 ROP and non-type 1 ROP subgroups. Results: There were 58 eyes of 31 infants that received neovascularization treatment that were included in the study. Of these 58 eyes, 41 had non-type 1 ROP, and 17 had type 1 ROP. 92.68% of the eyes treated for non-type 1 ROP had stage 3 ROP in zone II with pre-plus disease and 74.47% of the eyes treated for type 1 ROP had stage 3 ROP in zone II with plus disease. The mean gestational age and birth weight of the enrolled infants were 28.48 ± 1.99 weeks and 1165.32 ± 394.57 g, respectively. Unfavorable outcomes after neovascularization treatment occurred in three eyes (17.65%) in the type 1 ROP group, but there were no unfavorable outcomes in the non-type 1 ROP group (p=0.022); these three eyes were treated with laser indirect ophthalmoscopy (LIO) combined with Intravitreal bevacizumab (IVB). The non-type 1 ROP treated with laser LIO alone group had 100% regression, whereas type 1 ROP treated with LIO or combined LIO and IVT bevacizumab group had 82.35% regression. Progression after treatment without regression occurred in five eyes (29.41%) with type 1 ROP, but no progression occurred in eyes with non-type 1 ROP (p=0.001). Conclusion: Neovascularization treatment in non-type 1 ROP is useful for preventing unfavorable outcomes and achieving the regression of neovascularization, especially for diseases less severe than type 1 ROP. Moreover, neovascularization treatment in non-type 1 ROP can reduce the progression of ROP disease.

show abstract

Anatomic outcomes of laser indirect ophthalmoscopy for retinopathy of prematurity in a tertiary referral center in the Philippines

Cited by 3 publications

References 15 publications

Comparison of the detection rates for retinopathy of prematurity (ROP) of the 2013 Philippine Academy of Ophthalmology (PAO) Revised Philippine Guidelines and the 2005 PAO-Philippine Pediatric Society (PPS) Guidelines for ROP screening in the Philippine General Hospital: a 5-year review

Comparison of the detection rates for retinopathy of prematurity (ROP) of the 2013 Philippine Academy of Ophthalmology (PAO) Revised Philippine Guidelines and the 2005 PAO-Philippine Pediatric Society (PPS) Guidelines for ROP screening in the Philippine General Hospital: a 5-year review

Impact and Trends in Global Ophthalmology

Evaluation of Outcomes and Regression after Neovascularization Treatment for Non-type 1 Retinopathy of Prematurity

Contact Info

Product

Resources

About